Immunomodulatory effects of Erythropoietin in kidney transplantatio
Recruiting
- Conditions
- Z94.0Kidney transplant status
- Registration Number
- DRKS00032934
- Lead Sponsor
- Charité Universitätsmedizin Berlin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Kidney transplant patients, kidney transplantation >12 month before enrolment, stable immunosuppressive regimen, anemia with hemoglobin < 10g/dl
Exclusion Criteria
acute rejection, haemoglobin >11g/dl after enrolment, acute kidney injury
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase in regulatory T cell populations in blood by 20% and reduction of effector T cells and proinflammatory macrophages in urine by 20% after 4 EPO-administrations.
- Secondary Outcome Measures
Name Time Method - Hb increase by > 1g/dl